BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30915490)

  • 1. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
    Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
    Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
    Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
    Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Comparison Between Helical Tomotherapy and Volumetric Modulated Arc Therapy in Patients With Malignant Pleural Mesothelioma.
    Müdder T; Sarria GR; Henkenberens C; Holz J; Garbe S; Röhner F; Stumpf S; Buchstab T; Giordano FA; Leitzen C
    Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):164-171. PubMed ID: 34429236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
    Krayenbuehl J; Riesterer O; Graydon S; Dimmerling P; Kloeck S; Ciernik IF
    J Appl Clin Med Phys; 2013 Jul; 14(4):4130. PubMed ID: 23835378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
    Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
    Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
    Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
    Sterzing F; Sroka-Perez G; Schubert K; Münter MW; Thieke C; Huber P; Debus J; Herfarth KK
    Radiother Oncol; 2008 Feb; 86(2):251-7. PubMed ID: 18207597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
    Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
    Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
    Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
    Lorentini S; Amichetti M; Spiazzi L; Tonoli S; Magrini SM; Fellin F; Schwarz M
    Strahlenther Onkol; 2012 Mar; 188(3):216-25. PubMed ID: 22318326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma.
    Runxiao L; Yankun C; Lan W
    J Appl Clin Med Phys; 2016 Mar; 17(2):139-144. PubMed ID: 27074478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
    Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M
    Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.
    Li S; Zhou Q; Shen LF; Li H; Li ZZ; Yang Z; Lei MJ; Yang XY; Zhang ZJ; Hu YM; Jin ZF; Liu G; Lv ZP; Huang XQ
    Biomed Res Int; 2018; 2018():2653497. PubMed ID: 29967769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
    Allen AM; Schofield D; Hacker F; Court LE; Czerminska M
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1587-92. PubMed ID: 17892915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
    Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE
    Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma.
    Pehlivan B; Sengul K; Yesil A; Nalbant N; Ozturk O; Ozdemir Y; Topkan E
    Biomed Res Int; 2019; 2019():4568958. PubMed ID: 31930123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.